Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Watanabe, Yasuhiro
NCT04744532: iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study	Recruiting	1/2	49	Japan	Bosutinib (Phase 1 part), PF-05208763, Bosutinib (Phase 2 part)	Kyoto University, Tokushima University, Kitasato University, Tottori University, Nara Medical University, Toho University, Hiroshima University, Pfizer	Amyotrophic Lateral Sclerosis	03/24	03/24